A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Clinical trial NCT06780085 · RECRUITING
Trial details
- NCT number
- NCT06780085
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2032-03-12
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.